Grant: Operating Grant - Priority Announcement: Aging (Bridge Funding)
McMaster University
$100,000.00
Using the General Public to Estimate Health-related Quality-of-life in Alzheimer's Disease: Development and Validation of Clinical Vignettes
FY 2012-13
Summary
Quality-of-life (QoL) is important in Alzheimer's disease (AD) because no cure exists. Measuring QoL provides a way of assessing the 'humanistic element' of AD treatments. Patients and caregivers currently estimate QoL in AD by answering questionnaires. Question responses are converted into scores ranging from 0 (worst possible QoL or death) to 1 (perfect health). However, patients and caregivers give different QoL scores and very sick AD patients often cannot answer QoL questionnaires.
We will examine whether the general public can provide QoL scores in place of patients and caregivers. To do this, we will develop stories describing what happens to people who have mild, moderate, and severe AD. Patients, caregivers, and physicians will help us develop these stories. Afterward, we will conduct a survey that contains the stories and see if a sample of the general public in Canada gives QoL scores that decrease as disease severity increases.
Department
Program
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
273755
Name
Oremus Mark
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Health systems / services
Prcname2
Psychosocial, Sociocultural & Behavioural Determinants of Health 2
Projecttitle
Using the General Public to Estimate Health-related Quality-of-life in Alzheimer's Disease: Development and Validation of Clinical Vignettes
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Keyworddelim
Alzheimer'S Disease; Clinical Vignettes; Concurrent Validity; Focus Groups; General Public Survey; Health-Related Quality-Of-Life; Mixed Methods; Test-Retest Reliability
Abstract
Quality-of-life (QoL) is important in Alzheimer's disease (AD) because no cure exists. Measuring QoL provides a way of assessing the 'humanistic element' of AD treatments. Patients and caregivers currently estimate QoL in AD by answering questionnaires. Question responses are converted into scores ranging from 0 (worst possible QoL or death) to 1 (perfect health). However, patients and caregivers give different QoL scores and very sick AD patients often cannot answer QoL questionnaires.
We will examine whether the general public can provide QoL scores in place of patients and caregivers. To do this, we will develop stories describing what happens to people who have mild, moderate, and severe AD. Patients, caregivers, and physicians will help us develop these stories. Afterward, we will conduct a survey that contains the stories and see if a sample of the general public in Canada gives QoL scores that decrease as disease severity increases.
Competitiondate
201209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Oremus, Mark; Xie, Feng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~